Sanofi acquires 2.3% shares from L’Oréal in €3 billion buyback program
PARIS: Sanofi announced the acquisition of 2.3% of its shares from long-term shareholder L’Oréal as part of its share buyback program initiated on Jan. 30,...
Sanofi reports strong sales and earnings growth in 2023, driven by new products and pipeline
PARIS, FRANCE: Sanofi, a global leader in healthcare, announced today its financial results for the year 2023, showing a 5.3% increase in sales and a...
Sanofi to buy Inhibrx for $1.7 billion
PARIS, FRANCE: Sanofi, a global pharmaceutical company, has agreed to acquire Inhibrx, a clinical-stage biotech firm, for $30.0 per share in cash, or about $1.7...
Sanofi announces changes to its Executive Committee
PARIS, FRANCE: Sanofi, a global biopharmaceutical company, announced today the appointment of three new members to its Executive Committee and the departure of one of...
Sanofi to acquire Qunol, a leading U.S. brand in health & wellness
PARIS, FRANCE: Sanofi announced today that it has entered into a definitive agreement to acquire ownership of Qunol, a U.S.-based, market-leading brand in health &...
Sanofi to acquire Amunix Pharmaceuticals in a $1.225bn deal
PARIS, FRANCE: Sanofi has entered into an agreement to acquire Amunix Pharmaceuticals Inc, an immune-oncology company. Amunix’s pipeline, which includes lead candidate, AMX-818, a masked...
Sanofi to acquire Austrian Origimm Biotechnology GmbH
VIENNA, AUSTRIA: Sanofi has entered into an agreement to acquire Origimm Biotechnology GmbH, a news release said. Origimm Biotechnology is an Austrian privately owned biotechnology...
Sanofi invests $180mn in Owkin’s artificial intelligence and federated learning
PARIS, FRANCE: Sanofi announced an equity investment of $180 million and a new strategic collaboration with Owkin comprised of discovery and development programmes in four...
Sanofi to invest up to $60 million in Gyroscope Therapeutics
LONDON, UK: Sanofi, a global biopharmaceutical company, has committed to invest up to $60 million in equity of Gyroscope Therapeutics Holdings. Gyroscope plans to use...
Sanofi to create a €400 million vaccine production center in Singapore
PARIS: Sanofi announced a €400 million investment over five years to create a unique vaccine production center in Singapore. In partnership with the Singapore Economic...
Schroder UK sells its stake in Kymab Group to Sanofi for $82 million
LONDON: Schroder UK Public Private Trust (SUPP) has sold of its shares in Kymab Group Ltd. to Sanofi against initial proceeds of approximately US$82 million....
Sanofi, Capgemini, Generali and Orange to create e-health digital ecosystem
PARIS: Sanofi, Capgemini, Generali and Orange are forming a joint venture in France to fast-track the development of concrete healthcare solutions and to make them...